These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 14528214)

  • 1. Diagnosis and management of hereditary non-polyposis colon cancer.
    DeFrancisco J; Grady WM
    Gastrointest Endosc; 2003 Sep; 58(3):390-408. PubMed ID: 14528214
    [No Abstract]   [Full Text] [Related]  

  • 2. [The first molecular analysis of a Hungarian HNPCC family: a novel MSH2 germline mutation].
    Czakó L; Tiszlavicz L; Takács R; Baradnay G; Lonovics J; Cserni G; Závodná K; Bartosova Z
    Orv Hetil; 2005 May; 146(20):1009-16. PubMed ID: 15945244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identifying hereditary nonpolyposis colorectal cancer.
    Lynch HT; Smyrk TC
    N Engl J Med; 1998 May; 338(21):1537-8. PubMed ID: 9593794
    [No Abstract]   [Full Text] [Related]  

  • 4. Hereditary and somatic DNA mismatch repair gene mutations in sporadic endometrial carcinoma.
    Chadwick RB; Pyatt RE; Niemann TH; Richards SK; Johnson CK; Stevens MW; Meek JE; Hampel H; Prior TW; de la Chapelle A
    J Med Genet; 2001 Jul; 38(7):461-6. PubMed ID: 11474654
    [No Abstract]   [Full Text] [Related]  

  • 5. Re: Characterization of hereditary nonpolyposis colorectal cancer families from a population-based series of cases.
    Evans DG; Wu CL; Walsh S; Hansen I; Verma L; Robinson C; Kingston R; Maher ER
    J Natl Cancer Inst; 2001 May; 93(9):716-7. PubMed ID: 11333295
    [No Abstract]   [Full Text] [Related]  

  • 6. Molecular diagnostics of cancer predisposition: hereditary non-polyposis colorectal carcinoma and mismatch repair defects.
    Bocker T; Rüschoff J; Fishel R
    Biochim Biophys Acta; 1999 May; 1423(3):O1-O10. PubMed ID: 10382540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical findings with implications for genetic testing in families with clustering of colorectal cancer.
    Wijnen JT; Vasen HF; Khan PM; Zwinderman AH; van der Klift H; Mulder A; Tops C; Møller P; Fodde R
    N Engl J Med; 1998 Aug; 339(8):511-8. PubMed ID: 9709044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hereditary nonpolyposis colorectal cancer].
    Matsukawa M; Yamamoto T; Kouda T
    Nihon Rinsho; 2003 Sep; 61 Suppl 7():189-92. PubMed ID: 14574879
    [No Abstract]   [Full Text] [Related]  

  • 9. Screening families with endometrial and colorectal cancers for germline mutations.
    Liu T; Chen J; Salahshor S; Kuismanen S; Holmberg E; Grönberg H; Peltomäki P; Lindblom A
    J Med Genet; 2001 Sep; 38(9):E29. PubMed ID: 11546830
    [No Abstract]   [Full Text] [Related]  

  • 10. Molecular diagnosis of hereditary nonpolyposis colorectal cancer.
    O'Leary TJ
    JAMA; 1999 Jul; 282(3):281-2. PubMed ID: 10422999
    [No Abstract]   [Full Text] [Related]  

  • 11. Incidence of hereditary nonpolyposis colorectal cancer and the feasibility of molecular screening for the disease.
    Aaltonen LA; Salovaara R; Kristo P; Canzian F; Hemminki A; Peltomäki P; Chadwick RB; Kääriäinen H; Eskelinen M; Järvinen H; Mecklin JP; de la Chapelle A
    N Engl J Med; 1998 May; 338(21):1481-7. PubMed ID: 9593786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multimodal molecular screening is required to improve the sensitivity of MLH1 and MSH2 mutation analysis.
    Andermann A; Thiffault I; Wong N; Gordon P; MacNamara E; Chong G; Foulkes W
    J Clin Oncol; 2002 Mar; 20(6):1705-7. PubMed ID: 11896123
    [No Abstract]   [Full Text] [Related]  

  • 13. Genetic basis of familial endometrial cancer: is there more to learn?
    Boyd J
    J Clin Oncol; 2005 Jul; 23(21):4570-3. PubMed ID: 15837976
    [No Abstract]   [Full Text] [Related]  

  • 14. HNPCC: an uncommon but important diagnosis.
    Terdiman JP
    Gastroenterology; 2001 Oct; 121(4):1005-8. PubMed ID: 11606514
    [No Abstract]   [Full Text] [Related]  

  • 15. Carrier risk status changes resulting from mutation testing in hereditary non-polyposis colorectal cancer and hereditary breast-ovarian cancer.
    Watson P; Narod SA; Fodde R; Wagner A; Lynch JF; Tinley ST; Snyder CL; Coronel SA; Riley B; Kinarsky Y; Lynch HT
    J Med Genet; 2003 Aug; 40(8):591-6. PubMed ID: 12920070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mismatch repair gene defects contribute to the genetic basis of double primary cancers of the colorectum and endometrium.
    Millar AL; Pal T; Madlensky L; Sherman C; Temple L; Mitri A; Cheng H; Marcus V; Gallinger S; Redston M; Bapat B; Narod S
    Hum Mol Genet; 1999 May; 8(5):823-9. PubMed ID: 10196371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel splicing associations of hereditary colon cancer related DNA mismatch repair gene mutations.
    Renkonen E; Lohi H; Järvinen HJ; Mecklin JP; Peltomäki P
    J Med Genet; 2004 Jul; 41(7):e95. PubMed ID: 15235038
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical implications of genetic testing of hereditary nonpolyposis colorectal cancer.
    Vasen HF; Wijnen J
    Cytogenet Cell Genet; 1999; 86(2):136-9. PubMed ID: 10545704
    [No Abstract]   [Full Text] [Related]  

  • 19. Incidence of germline hMLH1 and hMSH2 mutations (HNPCC patients) among newly diagnosed colorectal cancers in a Slovenian population.
    Ravnik-Glavac M; Potocnik U; Glavac D
    J Med Genet; 2000 Jul; 37(7):533-6. PubMed ID: 10970186
    [No Abstract]   [Full Text] [Related]  

  • 20. Toward new strategies to select young endometrial cancer patients for mismatch repair gene mutation analysis.
    Berends MJ; Wu Y; Sijmons RH; van der Sluis T; Ek WB; Ligtenberg MJ; Arts NJ; ten Hoor KA; Kleibeuker JH; de Vries EG; Mourits MJ; Hollema H; Buys CH; Hofstra RM; van der Zee AG
    J Clin Oncol; 2003 Dec; 21(23):4364-70. PubMed ID: 14645426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.